Standout Papers

The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics 2003 2026 2010 2018 2.0k
  1. The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics (2008)
    Jon O. Lundberg, Eddie Weitzberg et al. Nature Reviews Drug Discovery
  2. Sickle-cell disease (2010)
    David C. Rees, Thomas N. Williams et al. The Lancet
  3. Updated Clinical Classification of Pulmonary Hypertension (2009)
    Gérald Simonneau, Ivan M. Robbins et al. Journal of the American College of Cardiology
  4. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation (2003)
    Jack H. Crawford, Rakesh P. Patel et al. Nature Medicine
  5. The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin (2005)
    Russell P. Rother, Leonard Bell et al. JAMA
  6. Right Ventricular Function and Failure (2006)
    Norbert F. Voelkel, Robert A. Quaife et al. Circulation
  7. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease (2002)
    Christopher D. Reiter, Xunde Wang et al. Nature Medicine
  8. Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease (2004)
    Mark T. Gladwin, Vandana Sachdev et al. New England Journal of Medicine
  9. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease (2002)
    Christopher D. Reiter, Xunde Wang et al. Nature Medicine
  10. Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes (2006)
    Gregory J. Kato, Mark T. Gladwin et al. Blood Reviews
  11. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver (2005)
    Mark R Duranski, James J.M. Greer et al. Journal of Clinical Investigation
  12. Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy (2016)
    Jason J. Rose, Ling Wang et al. American Journal of Respiratory and Critical Care Medicine
  13. Strategies to increase nitric oxide signalling in cardiovascular disease (2015)
    Jon O. Lundberg, Mark T. Gladwin et al. Nature Reviews Drug Discovery
  14. Nitric Oxide Scavenging by Red Blood Cell Microparticles and Cell-Free Hemoglobin as a Mechanism for the Red Cell Storage Lesion (2011)
    Chenell Donadee, Nicolaas J.H. Raat et al. Circulation
  15. Intravascular hemolysis and the pathophysiology of sickle cell disease (2017)
    Gregory J. Kato, Martin H. Steinberg et al. Journal of Clinical Investigation
  16. Pathophysiology of Sickle Cell Disease (2018)
    Prithu Sundd, Mark T. Gladwin et al. Annual Review of Pathology Mechanisms of Disease
  17. Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2018)
    Jesús Tejero, Sruti Shiva et al. Physiological Reviews
  18. Research Priorities for Heart Failure With Preserved Ejection Fraction (2020)
    Sanjiv J. Shah, Barry A. Borlaug et al. Circulation
  19. Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association (2019)
    Jay Giri, Akhilesh K. Sista et al. Circulation

Immediate Impact

5 by Nobel laureates 6 from Science/Nature 102 standout
Sub-graph 1 of 14

Citing Papers

De novo design of allosterically switchable protein assemblies
2024 StandoutNatureNobel
Heart failure with preserved ejection fraction: everything the clinician needs to know
2024 Standout
14 intermediate papers

Works of Mark T. Gladwin being referenced

Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction
2018
SIRT3–AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
2016
and 14 more

Author Peers

Author Last Decade Papers Cites
Mark T. Gladwin 13872 15277 10151 510 42.8k
Alan N. Schechter 6919 6711 4922 302 18.9k
Ernest Beutler 8893 13720 8184 749 44.1k
Stefanie Dimmeler 11002 9518 2890 512 71.9k
Andreas M. Zeiher 9437 10443 2811 548 68.1k
Russell Ross 2452 7181 5183 241 78.4k
Kenneth Walsh 3002 12861 2268 456 53.0k
Franklin H. Epstein 1485 8699 2363 251 56.3k
Thomas F. Lüscher 1667 16237 2869 1.1k 61.0k
Asrar B. Malik 1581 6428 3139 578 39.7k
John R. Vane 1888 18230 1510 461 62.4k

All Works

Loading papers...

Rankless by CCL
2026